Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells

Despite the benefits associated with radiotherapy and chemotherapy for glioblastoma (GBM) treatment, most patients experience a relapse following initial therapy. Recurrent or progressive GBM usually does not respond anymore to standard therapy, and this is associated with poor patient outcome. GBM...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Nucleic Acids
Main Authors: Affinito, Alessandra, Quintavalle, Cristina, Esposito, Carla Lucia, Roscigno, Giuseppina, Giordano, Catello, Nuzzo, Silvia, Ricci-Vitiani, Lucia, Scognamiglio, Iolanda, Minic, Zoran, Pallini, Roberto, Berezovski, Maxim V., de Francisis, Vittorio, Condorelli, Gerolama
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7068199/
https://ncbi.nlm.nih.gov/pubmed/32169805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2020.02.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados